SpaceX shares traded below $135 in Thursday premarket sessions, the first time secondary-market pricing has broken the company's recent effective entry level since institutional blocks began circulating last month. The move erases the modest premium that had held through initial placement, leaving early institutional buyers at or below cost basis.
The company carried no public listing until structured secondary sales began in late March, with placement handled through Morgan Stanley at $135 per share for qualified institutional buyers. That figure implied a $250 billion fully-diluted valuation, making it the second-highest private company by market capitalization globally behind ByteDance. Thursday's breach means the premium that justified entry—Starlink's revenue ramp, Pentagon contracts, Starship's orbital cadence—is being repriced in real time by funds with six-month lockups and limited liquidity.
The timing compounds. SpaceX disclosed April 15 that Starlink subscriber growth in North America decelerated 18% quarter-over-quarter, missing internal projections by 220,000 units. Two days later, the Pentagon's Space Development Agency awarded $1.1 billion in tracking-layer contracts to Northrop Grumman and L3Harris, omitting SpaceX from a program it had been favored to win. Starship's fourth orbital test, planned for late April, slipped to mid-May without explanation. Allocators who priced in $8.5 billion in 2024 Starlink revenue are now working with analyst cuts in the $7.2 billion range. The valuation assumed 42% compounding on space-services revenue; the subscriber miss implies 31%, which is still strong but removes the scarcity bid.
The breach matters less for SpaceX's operational reality—launch cadence is up 29% year-over-year, Starship is flying, the company is not capital-constrained—and more for what it signals about private-market discipline returning. For eighteen months, late-stage technology companies carried valuations that assumed flawless execution and infinite duration of the risk-free rate near zero. SpaceX was the highest-quality name in that cohort, which made it the least vulnerable. The fact that even $250 billion SpaceX is being marked down suggests allocators are repricing duration and implementation risk across every private book with a $5 billion-plus stub.
Family offices and fundless sponsors who bought SpaceX in secondary at $135 now face a decision: average down at $128–$132, where shares are currently being whispered, or wait for the Starship flight in mid-May to reset sentiment. The Starlink revenue miss is a one-quarter data point; the Pentagon contract loss is more durable, as it signals DoD diversification away from single-vendor reliance. The company's next liquidity event—whether a Starlink spinoff IPO or another tender—will likely price in the $210 billion to $230 billion range unless Starship demonstrates full reusability before year-end. That outcome is possible but not a given. The allocators who entered at $135 were pricing certainty; the market is now pricing aerospace.
Morgan Stanley's structured desk is expected to mark its book by end of week. Funds with March vintage SpaceX exposure will report those marks in Q2 letters, which go out in mid-July. The valuation reset will cascade.